← Eichor
Study identifier: NCT06163547 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Middle Meningeal Artery Embolization for Chronic Subdural Hematomas (STORMM)

Condition: Chronic Subdural Hematomas · Cerebral Compression Due to Injury  ·  Sponsor: University Hospital, Geneva

PhaseNA
Planned participants180
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

Chronic Subdural Hematomas (cSHD) are common, and due to cerebral compression, often result in neurological impairment and reduced consciousness. Surgery is typically performed once neurological symptoms develop. Recent studies suggest that arteries nourished by the middle meningeal artery (MMA) may be responsible for hematoma progression and that MMA embolization is clinically useful. There is less evidence, that embolization of MMA also may be a treatment option for individuals without surgical treatment. The investigators propose a multicentre study to investigate both potentials: (1) Assessment of efficacy of embolization after surgery to reduce recurrence and improve outcomes by conducting a randomized trial (randomization arms; Arms 1 and 2), (2) Assessment of embolization-alone efficacy when surgery is contraindicated or refused (embolization-only arm, Arms 3 and 4).

This description comes directly from the study's public registry record.

Talk to the study team

Aria Nouri  ·  +41795530958  ·  aria.nouri@hug.ch

Always discuss trial participation with your own doctor first.

Locations (2)

Geneva University HospitalsGeneva, SwitzerlandRecruiting
EOCLugano, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06163547